Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
China · Delayed Price · Currency is CNY 6.32
+0.02 (0.32%)
Jan 23, 2026, 3:04 PM CST
SHE:002022 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -750.99 | -640.6 | -234.01 | 971.56 | 850.41 | 675.36 | Upgrade |
Depreciation & Amortization | 246.46 | 246.46 | 215.98 | 213.36 | 153.18 | 133.8 | Upgrade |
Other Amortization | 12.85 | 12.85 | 10.3 | 6.23 | 5.1 | 4.15 | Upgrade |
Loss (Gain) From Sale of Assets | -4.21 | -4.21 | -5.02 | -4.53 | -2.06 | -4.68 | Upgrade |
Asset Writedown & Restructuring Costs | 93.25 | 93.25 | 82.59 | 145.97 | 15.61 | 10.96 | Upgrade |
Loss (Gain) From Sale of Investments | -10.8 | -10.8 | -24.41 | -3.9 | 1.96 | -1.44 | Upgrade |
Provision & Write-off of Bad Debts | 187.77 | 187.77 | 14.08 | 73.33 | 14.56 | 11.25 | Upgrade |
Other Operating Activities | 248.64 | 92.58 | 194.36 | 820.69 | 542.92 | 556.36 | Upgrade |
Change in Accounts Receivable | 105.03 | 105.03 | 271.54 | -407.28 | -264.82 | -324.9 | Upgrade |
Change in Inventory | -34.89 | -34.89 | 197.21 | -536.6 | -57.91 | -257.84 | Upgrade |
Change in Accounts Payable | -80.24 | -80.24 | -1,127 | 948.64 | -185.36 | 605.09 | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | - | 0.89 | Upgrade |
Operating Cash Flow | -4.45 | -50.12 | -474.89 | 2,154 | 1,079 | 1,367 | Upgrade |
Operating Cash Flow Growth | - | - | - | 99.55% | -21.06% | 449.36% | Upgrade |
Capital Expenditures | -170.32 | -254.82 | -330.93 | -427.91 | -216.03 | -257.72 | Upgrade |
Sale of Property, Plant & Equipment | 7.34 | 6.27 | 16.34 | 22.3 | 7.26 | 14.96 | Upgrade |
Cash Acquisitions | - | - | - | -6.12 | - | - | Upgrade |
Divestitures | 1 | - | - | - | - | - | Upgrade |
Investment in Securities | 148.25 | 311.5 | -315 | - | -8.91 | -3.48 | Upgrade |
Other Investing Activities | 5.24 | 12.92 | 23.17 | 3.9 | 5.18 | 0.07 | Upgrade |
Investing Cash Flow | -8.49 | 75.87 | -606.42 | -407.82 | -212.49 | -246.17 | Upgrade |
Short-Term Debt Issued | - | - | - | 10.4 | 0.68 | - | Upgrade |
Long-Term Debt Issued | - | 399.78 | 199.57 | 159.53 | 269.23 | 578.14 | Upgrade |
Total Debt Issued | 660.25 | 399.78 | 199.57 | 169.93 | 269.91 | 578.14 | Upgrade |
Long-Term Debt Repaid | - | -892.95 | -232.17 | -233.81 | -573.57 | -613.73 | Upgrade |
Net Debt Issued (Repaid) | 212.17 | -493.17 | -32.6 | -63.87 | -303.66 | -35.59 | Upgrade |
Issuance of Common Stock | - | - | - | 0.7 | 5.09 | 725.66 | Upgrade |
Repurchase of Common Stock | -101.02 | -101.02 | - | -0.12 | -3.03 | -2.1 | Upgrade |
Common Dividends Paid | -13.01 | -24.44 | -318 | -854.8 | -117.88 | -90.52 | Upgrade |
Other Financing Activities | -86.6 | -155.52 | -446.63 | 142.95 | -136.3 | 0.5 | Upgrade |
Financing Cash Flow | 11.54 | -774.15 | -797.23 | -775.14 | -555.78 | 597.96 | Upgrade |
Foreign Exchange Rate Adjustments | 7.21 | 3.16 | 9.26 | 51.56 | -9.79 | -9.52 | Upgrade |
Net Cash Flow | 5.8 | -745.23 | -1,869 | 1,022 | 301.15 | 1,709 | Upgrade |
Free Cash Flow | -174.77 | -304.94 | -805.82 | 1,726 | 863.19 | 1,109 | Upgrade |
Free Cash Flow Growth | - | - | - | 99.92% | -22.20% | 921.03% | Upgrade |
Free Cash Flow Margin | -10.92% | -17.33% | -33.19% | 24.76% | 17.78% | 26.70% | Upgrade |
Free Cash Flow Per Share | -0.34 | -0.60 | -1.57 | 3.24 | 1.62 | 2.16 | Upgrade |
Cash Income Tax Paid | 63.65 | 86.74 | 133.52 | 686.58 | 508.21 | 319.94 | Upgrade |
Levered Free Cash Flow | 148.15 | -154.66 | -786.2 | 1,401 | 494.8 | 753.63 | Upgrade |
Unlevered Free Cash Flow | 164.47 | -128.27 | -758.86 | 1,426 | 519.89 | 775.47 | Upgrade |
Change in Working Capital | -27.42 | -27.42 | -728.77 | -69.07 | -502.47 | -18.57 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.